Discontinuing Beta-blocker therapy after an uncomplicated myocardial infarction (MI) was found to cause a persistent rise in ...

acute- and post-myocardial infarction, and congestive heart failure. However, β blockers do not all share the same clinical outcomes with respect to efficacy or safety in many of these conditions.

Heart failure with reduced ejection fraction (HFrEF) represents a significant global health burden, affecting over 64 million individuals and resulting in substantial morbidity and mortality, ...

The findings hint at why the ABYSS trial failed to show it was safe to stop beta-blockers after an MI in stable patients.

Drug therapies for patients with acute heart failure syndromes (AHFS ... angiotensin-receptor blockers, β-blockers, and aldosterone antagonists, during the patient's hospital stay in an effort ...

Aficamten was associated with improved peak oxygen uptake and a tolerable safety profile vs. metoprolol, a beta-blocker, in ...

This is the reality of congestive heart failure ... ACE inhibitors or angiotensin receptor blockers relax blood vessels and reduce strain on the heart. Beta blockers slow heart rate and reduce ...

You’re not wrong. Beta blockers are a type of medication used to treat heart conditions and cardiovascular diseases, like congestive heart failure, heart attacks, coronary artery disease (aka ...

Around 3,000 lives could be saved and 5,500 hospital admissions prevented each year by changes to how people are treated for heart failure, according to a watchdog. New draft guidelines from the ...

Thousands could be saved by making this small change to heart failure treatment - Giving medication up to a year earlier ...

Patients with COPD and established cardiovascular disease have more MACEs and seek less preventive cardiac care than patients with CVD alone.

EMJ spoke with Srihari S. Naidu, who shared insights into his pioneering work in alcohol septal ablation, his contributions ...